medigraphic.com
ISSN 0016-3813 (Print)

2007, Number 3

<< Back Next >>

Gac Med Mex 2007; 143 (3)

Linfoma de células B de la zona marginal extraganglionar del tejido linfoide asociado a mucosas (linfoma MALT). Evolución histórica y conceptos actuales.

Piña-Oviedo S, Ortiz-Hidalgo C

Language: Spanish
References: 62
Page: 237-244
PDF size: 220.14 Kb.


ABSTRACT

Significant advances in the understanding of marginal zone lymphoma since the first description in 1983 by Peter Isaacson and Dennis Wright have been noted. MALT lymphomas are a subgroup of low-grade B-cell lymphomas that arise from extranodal sites, comprising 7-8% of all B-cell lymphomas and displaying distinct clinicopathological characteristics. MALT lymphomas remain localized in the primary site for long periods of time and seldom disseminate unto other organs. These type of lymphomas infrequently arise in native MALT, but instead arise in MALT acquired in the course of chronic inflammatory disorders, such as Sjögren’s syndrome and Helicobacter pylori infection. Eradication of H. pylori produces a clinical regression of the lymphoma in about 75% of cases. The histological hallmarks of MALT lymphoma include neoplastic centrocyte-like B cells, cells resembling monocytoid cells and the presence of lymphoepithelial lesions. The gastrointestinal tract, particularly the stomach, include two-thirds of cases; however MALT lymphomas also occur in other organs such as salivary glands, lung, thyroid, ocular adnexa, breast and skin. Genetic studies have identified three chromosomal translocations specifically associated with MALT lymphomas that include: t(11:18)(q21;q21), t(1;14)(p22;q32), and t(14;18)(q32;q21). Although these translocations involve different genes, they appear to share a common oncogenic pathway involving NFκB.


REFERENCES

  1. Isaacson PG, Müller-Hermelink HK, Piris MA, Berger F, Nathwani BN, Swerdlow SH, et al. Extranodal marginal zone B-cell lymphoma of mucosaassociated lymphoid tissue (MALT lymphoma). En: World Health Organization Classification of Tumours: Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues. Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds). IARC Press. Lyon, 2001, pp 157-160.

  2. Campo E, Chott A, Kinney MC, Leoncini L, Meijer CJ, Papadimintriou CS, et al. Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece. Histopathology 2006;48:481-504.

  3. Isaacson PG, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinct type of B-cell lymphoma. Cancer 1983;52:1410-1416.

  4. Isaacson PG, Wright DH. Extranodal malignant lymphoma arising from mucosa associated lymphoid tissue. Cancer 1984;53:2515-2524.

  5. Isaacson PG, Du Ming-Quing. MALT lymphoma: from morphology to molecules. Nature Rev Cancer 2004;4:644-652.

  6. Isaacson PG, Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 1987;11:445-462.

  7. Ferry JA, Harris NL. Non-Hodgkin’s Lymphomas. En: Atlas of Lymphoid Hyperplasia and Lymphoma. Chapter 3. B-Cell Neoplasms. W. B. Saunders Company. Philadelphia, PA. 1997;92-99.

  8. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-1176.

  9. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosaassociated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-577.

  10. Farinha P, Gascoyne RD. Helicobacter pylori and MALT lymphoma. Gastroenterology 2005;128;1579-1605.

  11. Parsonnet J, Isaacson PG. Bacterial infection and MALT lymphoma. N Eng J Med 2004;350:213-215.

  12. Ferreri AJ, Guidoboni M, Ponzoni M, De Conciliis C, Dell’Oro S, Fleischhauer K, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 2004;96:586-594.

  13. Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F, et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Eng J Med 2004;350:239-248.

  14. Slater DN. Borrelia burgdorferi-associated primary cutaneous B-cell lymphoma. Histopathology 2001;38:73-77.

  15. Fox JG. The non-H pylori helicobacters: their expading role in gastrointestinal and systemic diseases. Gut 2002;50:273-283.

  16. De Vita S, De Re V, Sansonno D, Sorrentino D, Corte RL, Pivetta B, et al. Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis. Hepatology 2000;31:182-189.

  17. Dogan A, Du M, Koulis A, Briskin MJ, Isaacson PG. Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue. Am J Pathol 1997;151:1361-1369.

  18. Du MQ, Peng HZ, Dogan A, Diss TC, Liu H, Pan LX, et al. Preferential dissemination of B-cell gastric mucosa-associated lymphoid tissue (MALT) lymphoma to the splenic marginal zone. Blood 1997;90:4071-4077.

  19. Isaacson PG, Diss TC, Wotherspoon AC, Barbazza R, De Boni M, Doglioni C. Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibiotics. Gastroenterology 1999;117:750-751.

  20. Thieblemont C. Clinical presentation and management of marginal zone lymphomas. Hematology (Am Soc Hematol Educ Program) 2005;307-313.

  21. Myhre MJ, Isaacson PG. Primary B-cell gastric lymphoma –a reassessment of its histogenesis. J Pathol 1987;152:1-11.

  22. Spencer J, Perry ME, Dunn-Walters DK. Human marginal-zone B cells. Immunol Today 1998;19:421-426.

  23. Morse HC 3rd, Kearney JF, Isaacson PG, Carroll M, Fredrickson TN, Jaffe ES. Cells of the marginal zone—origins, function and neoplasia. Leuk Res 2001;25:169-178.

  24. Camacho FI, García JF, Sánchez-Verde L, Sáez AI, Sánchez-Beato M, Mollejo M, et al. Unique phenotypic profile of monocytoid B cells: differences in comparison with the prenotypic profile observed in marginal zone B cells and so-called monocytoid B cell lymphoma. Am J Pathol 2001;158:1363-1369.

  25. Hsi ED, Eisbruch A, Greenson JK, Singleton TP, Ross CW, Schnitzer B. Classification of primary gastric lymphomas according to histologic features. Am J Surg Pathol 1998;22:17-27.

  26. García JF, Piris MA, Morente MM. Procesos linfoproliferativos no Hodgkin de células B. Rev Esp Patol 2004;37:139-158.

  27. Rooney N, Dogan A. Gastrointestinal lymphoma. Curr Diagn Pathol 2004;10:69-78.

  28. Kurtin PJ. Marginal zone B cells, monocytoid B cells, and the follicular microenvironment. Determinants of morphologic features in a subset of lowgrade B-cell lymphomas. Am J Clin Pathol 2000;114:505-508.

  29. Ortiz-Hidalgo C, Wright DH. The morphological spectrum of monocytoid Bcell lymphoma and its relationship to lymphomas of mucosa-associated lymphoid tissue. Histopathology 1992;21:555-561.

  30. Ye H, Dogan A, Karran L, Willis TG, Chen L, Wlodarska I, et al. BLC10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma. Am J Pathol 2000;157:1147-1154.

  31. Dierlamm J, Pittaluga S, Wlodarska I, Stul M, Thomas J, Boogaerts M, et al. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood 1996;87:299-307.

  32. Dierlamm J, Baens M, Wlodarska I, Stefanova-Ouzounova M, Hernandez JM, Hossfeld DK, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999;93:3601-3609.

  33. Dierlamm J, Baens M, Stefanova-Ouzounova M, Hinz K, Wlodarska I, Maes B, et al. Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes. Blood 2000;96:2215-2218.

  34. Streubel B, Lamprecht A, Dierlamm J, Cerroni L, Stolte M, Ott G, et al. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003;101:2335-2339.

  35. Streubel B, Ye H, Du MQ, Isaacson PG, Chott A, Raderer M. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma. Oncology 2004;66:476-480.

  36. Willis TG, Jadayel DM, Du MQ, Peng H, Perry AR, Abdul-Rauf M, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999;96:35-45.

  37. Wotherspoon AC, Finn TM, Isaacson PG. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood 1995;85:2000-2004.

  38. Baens M, Maes B, Steyls A, Geboes K, Marynen P, De Wolf-Peters C. The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am J Pathol 2000;156:1433-1439.

  39. Isaacson PG, Du Ming-Qing. Gastrointestinal lymphoma: where morphology meets molecular biology. J Pathol 2005;255-274.

  40. Chuang SS, Lee C, Hamoudi RA, Liu H, Lee PS, Ye H, et al. High frequency of t(11;18) in gastric mucosa-associated lymphoid tissue lymphomas in Taiwan, including one patient with high-grade transformation. Br J Haematol 2003;120:97-100.

  41. Cook JR, Sherer M, Craig FE, Shekhter-Levin S, Swerdlow SH. T(14;18)(q32;q21) involving MALT1 and IGH genes in an extranodal diffuse large B-cell lymphoma. Hum Pathol 2003;34:1212-1215.

  42. Kuppers R, Dalla-Favera R. Mechanisms of chromosomal translocations in Bcell lymphomas. Oncogene 2001;20:5580-5594.

  43. Liu H, Hamoudi RA, Ye H, Ruskone-Fourmestraux A, Dogan A, Isaacson PG, et al. t(11;18)(q21;q21) of mucosa-associated lymphoid tissue lymphoma results from illegitimate non-homologous end joining following double strand breaks. Br J Haematol 2004;125:318-329.

  44. Ye H, Liu H, Attygalle A, Wotherspoon AC, Nicholson AG, Charlotte F, et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood 2003;102:1012-1018.

  45. Remstein ED, Kurtin PJ, Einerson RR, Paternoster SF, Dewald GW. Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving API2 and MALT1 and IGH and MALT1. Leukemia 2004;18:156-160.

  46. Streubel B, Huber D, Wohrer S, Chott A, Raderer M. Frequency of chromosomal aberrations involving MALT1 in mucosa-associated lymphoid tissue lymphoma in patients with Sjogren’s syndrome. Clin Cancer Res 2004;10:476-480.

  47. Isaacson PG. Update on MALT lymphomas. Best Pract Res Clin Haematol 2005; 18: 57-68.

  48. Lucas PC, McAllister-Lucas LM, Nunez G. NK-kappaB signaling in lymphocytes: a new cast of characters. J Cell Sci 2004;117:31-39.

  49. McAllister-Lucas LM, Inohara N, Lucas PC, Ruland J, Benito A, Li Q, et al. Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction. J Biol Chem 2001;276:30589-30597.

  50. Che T, You Y, Wang D, Tanner MJ, Dixit VM, Lin X. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptorinduced NF-kappaB activation. J Biol Chem 2004;279:15870-15876.

  51. Lucas PC, Yonezumi M, Inohara N, McAllister-Lucas LM, Abazeed ME, Chen FF, et al. Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NK-kappaB signaling pathway. J Biol Chem 2001;276:19012-19019.

  52. Ho L, Davis RE, Conne B, Chappuis R, Berczy M, Mhawech P, et al. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Blood 2005;105:2891-2899.

  53. Ruland J, Duncan GS, Elia A, del Barco Barrantes I, Nguyen L, Plyte S, et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NFkappaB and neural tube closure. Cell 2001;104:33-42.

  54. Ruland J, Duncan GS, Wakeham A, Mak TW. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 2003;19:749-758.

  55. Ye H, Gong L, Liu H, Hamoudi RA, Shirali S, Ho L, et al. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MATL1 and BCL10 expression. J Pathol 2005;205:293-301.

  56. Banham AH, Beasley N, Campo E, Fernandez PL, Fidler C, Gatter K, et al. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res 2001;61:8820-8829.

  57. Barrans SL, Fenton JA, Banham A, Owen RG, Jack AS. Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome. Blood 2004;104:2933-2935.

  58. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103:275-282.

  59. Alpen B, Neubauer A, Dierlamm J, Marynen P, Thiede C, Bayerdörffer E, et al. Traslocation t(11;18) absent in early gastric marginal zone B-cell lymphoma af MALT type responding to eradication of Helicobacter pylori infection. Blood 2000;95:4014-4015.

  60. Liu H, Ye H, Dogan A, Ranaldi R, Hamoudi RA, Bearzi I, et al. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 2001;98:1182-1187.

  61. Zucca E, Bertoni F, Roggero E, Cavalli F. The gastric marginal zone B-cell lymphoma of MALT type. Blood 2000;96:410-419.

  62. Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C, et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002;122: 1286-1294.




2020     |     www.medigraphic.com